Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Marshall Teitelbaum who wrote (1167)	11/15/1997 5:17:00 PM
From: David S.	Read Replies (2) \| Respond to of 2205

RE: ORG - A stock dividend from them is nothing more than a gimmick to help prop up a hidiously overvalued security. Based on Fridays action, it seemed to work, so now it's even more absurd. Re: ATIS, my opinion of the valuation assumes that they get product approval. The tissue paper analogy is from doctors who have experience with the product. I have a general question - given the market environment, with good companies that have positive eps and who are growing that eps very nicely - their stocks being buffeted about like the Minnow in Gilligan's Island during the storm - why would people choose to own biotechs in general that are not profitable, whose future eps stream is vastly more uncertain than every other sector of the market? I believe there is a time in a market cycle to own biotechs, but to believe that now is the time - I find that hard to believe.